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Abstract
Acute exacerbations of pulmonary fibrosis are characterized by rapid decrements in lung function. Environmental factors
that may contribute to acute exacerbations remain poorly understood. We have previously demonstrated that exposure to
inhaled lipopolysaccharide (LPS) induces expression of genes associated with fibrosis. To address whether exposure to LPS
could exacerbate fibrosis, we exposed male C57BL/6 mice to crystalline silica, or vehicle, followed 28 days later by LPS or
saline inhalation. We observed that mice receiving both silica and LPS had significantly more total inflammatory cells, more
whole lung lavage MCP-1, MIP-2, KC and IL-1b, more evidence of oxidative stress and more total lung hydroxyproline than
mice receiving either LPS alone, or silica alone. Blocking oxidative stress with N-acetylcysteine attenuated whole lung
inflammation but had no effect on total lung hydroxyproline. These observations suggest that exposure to innate immune
stimuli, such as LPS in the environment, may exacerbate stable pulmonary fibrosis via mechanisms that are independent of
inflammation and oxidative stress.
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Introduction
The factors that contribute to the pathogenesis and progression
of fibrotic lung disease remain poorly understood. Fibrotic lung
disease may be caused by inhalation of organic or inorganic
substances, by medications or infection; may be associated with
clinical conditions such as connective tissue disease; or may be
idiopathic in nature. Rates of incidence and prevalence of fibrotic
lung diseases are difficult to estimate, although a recent study
shows that incidence can range between 19.4 and 34.3 per
100,000 [1]. In particular, exposure to crystalline silica in
occupational settings has historically been estimated to be in the
millions annually in the US alone [2] and thus continues to be
a significant occupational risk factor. We use crystalline silica
instillation in mice as a clinically relevant model of human disease
because silica instillation leads to lung injury that is consistent and
uniformly similar with pulmonary lesions observed in patients with
occupational silicosis.
Broadly, fibrotic lung diseases may be characterized as slowly
progressing, rapidly progressing or punctuated by episodes of
disease acceleration known as acute exacerbations [3]. It is
increasingly recognized that a significant portion of the population
with interstitial lung diseases that develop lung fibrosis suffer from
episodes of accelerated disease progression for unknown reasons
[4,5,6]. Acute exacerbations of pulmonary fibrosis occur in
approximately 14% of patients with idiopathic pulmonary fibrosis
each year [7]. The differences between slowly and rapidly
progressing fibrotic lung disease are becoming somewhat more
clear [8] although the causes for these differences remain obscure.
Similarly, the causes of acute exacerbations of lung fibrosis remain
to be determined. First described in 1993 [9], the definition of an
acute exacerbation has come to include 1) increased dyspnea
within 1 month; 2) hypoxemia; 3) new pulmonary infiltrates that
are visible by radiography; and 4) absence of infection or evidence
of a cardiac event [10]. The idiopathic and apparently stochastic
nature of acute exacerbations renders them very difficult to study.
Nevertheless, some attempts have been made to identify mechan-
isms that could contribute to such exacerbation events. For
example, viral infections have frequently been observed in cases of
lung fibrosis [11], and viral accelerations of lung fibrosis have been
successfully modeled in mice and are characterized by Th1
cytokine and fibrogenic growth factor expression that is consistent
with activation of innate immunity [12,13]. Viral particles are
recognized by Pathogen Associated Molecular Pattern (PAMP)
receptors in the Toll-Like Receptor (TLR) family and are able to
activate an innate immune response in the lung. We have
previously shown that innate immune stimulation of the lung with
the canonical activator of innate immunity, lipopolysaccharide
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(LPS), can increase expression of genes commonly associated with
lung fibrosis and can induce fibroproliferative airway remodeling
[14]. Therefore, our overall hypothesis is that environmental
exposures that activate innate immunity contribute to acceleration
of or exacerbation of stable pulmonary fibrosis. To address this
hypothesis, we first exposed mice to crystalline silica in the lung
and 28 days later, exposed these mice to LPS by aerosol
inhalation. Our observations suggest that exposure to LPS, or
other common environmental exposures that activate innate
immunity, could contribute to acceleration of, or acute exacerba-
tions of fibrotic lung disease in patients with pulmonary fibrosis.
Materials and Methods
Animals and Exposures
Eight week old male C57BL/6 male mice (Jackson Laboratory,
Bar Harbor, ME) were given a single oropharyngeal aspiration of
0.2 g/kg crystalline silica (Min-U-Sil 5 [15,16]; a generous gift
from Dr. Andy Ghio, US Environmental Protection Agency) in
60 ml of sterile 0.9% saline or an equivalent volume of 0.9% saline
alone at day 0. On day 28, groups of mice (n = 6/group) were then
either exposed to an aerosol of LPS as previously described [17] at
a target concentration of 0.5 mg/m3 or to an aerosol of sterile
0.9% saline for 2.5 hours per day for five consecutive days under
barrier conditions. Groups of mice were then sacrificed immedi-
ately after the end of the last LPS exposure or were allowed to
recover for 21 days before sacrifice. Treatment groups are referred
to by exposures in the order administered. Saline-Saline first
received the vehicle control for silica via oropharyngeal aspiration
followed 28 days later by the aerosolized saline control for LPS;
Saline-LPS first received the vehicle control for silica via
oropharyngeal aspiration followed 28 days later by aerosolized
LPS; Silica-Saline first received 0.2 g/kg silica via oropharyn-
geal aspiration followed 28 days later by the aerosolized saline
control for LPS, and; Silica-LPS first received 0.2 g/kg silica via
oropharyngeal aspiration followed 28 days later by aerosolized
LPS. Mice treated with N-acetylcysteine (NAC) were provided
with drinking water supplemented with 2 mg/ml NAC as
described previously [18] for the period beginning three days
prior to the start of LPS inhalation and lasting until phenotyping
(n = 8/group). All animal procedures were approved by the Duke
University Institutional Animal Care and Use Committee.
Hydroxyproline Analysis
Whole lungs were lyophilized and then acid hydrolyzed in
sealed, oxygen-purged glass ampules containing 2 ml of 6 N HCl
at 110uC for 24 h. Samples were resuspended in 1.5 ml of
phosphate buffered saline and incubate at 60uC for 1 h. Samples
were centrifuged at 13,000 rpm for 10 min. and the hydroxypro-
line analysis was performed on the resulting supernatant using
chloramine-T spectrophotometric absorbance as previously de-
scribed [19].
Lung Histology
Lung sections were stained with Masson’s trichrome to visualize
collagen. Images were captured at either 56 or 206magnifica-
tion, and the color balance for each image was adjusted equally
using Adobe Photoshop.
Analysis of Bronchoalveolar Lavage Fluid (BALF)
Mice were euthanized by CO2 inhalation, and lungs were
lavaged three times to capacity with 0.9% saline through PE-90
tubing at a pressure of 20 cmH2O. The collected lavage fluid was
processed and stored for further analysis as previously described
[20]. Total MCP-1, MIP-2 and KC concentrations in the BALF
were determined using Duo-Set ELISA kits (R&D Systems;
Minneapolis MN) according to the manufacturer’s instructions.
Protein carbonyl content of the BALF was determined using the
Cell BioLabs, Inc (San Diego, CA) OxiSelectTM protein carbonyl
ELISA kit according to the manufacturer’s instructions.
Statistical Analyses
All data are expressed as means 6 SE. Differences between
groups and between variables were analyzed by ANOVA.
Probability values of P,0.05 (two-tailed) were considered statis-
tically significant.
Results
Innate Immune Stimulation Significantly Increases Total
Lung Hydroxyproline Content in Mice Previously Exposed
to Crystalline Silica
To address whether innate immune stimulation would contrib-
ute to pre-existing lung fibrosis, we first exposed 8 week old
C57BL/6 mice to either crystalline silica or vehicle alone via
oropharyngeal aspiration. This was followed 28 days later by
exposure of these groups of mice to either aerosolized LPS or
sterile saline. We observed that immediately and 21 days after the
aerosol exposure (Figure 1) there was no difference in total lung
hydroxyproline between Saline-Saline (closed square) and Saline-
LPS groups (open square), indicating that LPS exposure by itself
did not increase total lung hydroxyproline in these mice. Both
immediately and 21 days after the aerosol exposure (Figure 1) we
observed that exposure to crystalline silica by itself (Silica-Saline
group, closed triangle) significantly increased total lung hydro-
xyproline content when compared with the Saline-Saline group.
Importantly, we observed that mice exposed to both silica and
inhaled LPS (Silica-LPS, open triangle) had significantly more
total lung hydroxyproline than control mice exposed to saline
alone (Saline-LPS), or mice exposed to silica alone (Silica-Saline).
These observations taken together demonstrate that activation of
the innate immune system in the lung increases total lung
hydroxyproline in mice with pre-existing lung fibrosis.
Figure 1. Hydroxyproline content in whole lung tissue. Total
hydroxyproline per lung immediately after and 21 days after the end of
inhalation challenge. Data are presented as Mean + SEM and are
representative of two such experiments. n = 6/group. * p,0.05 LPS vs.
Saline (significant difference due to inhalation challenge); # p,0.05
Silica vs. Saline (significant difference due to silica instillation or
combined Silica and LPS).
doi:10.1371/journal.pone.0040789.g001
LPS Exacerbates Pulmonary Fibrosis in Mice
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The significant increases in hydroxyproline associated with LPS
inhalation challenge consequent to silica instillation may be
appreciated histologically as shown in Figure 2 (immediately after)
and Figure 3 (21 days after). We observed that immediately after
either saline or LPS inhalation challenges (Saline-Saline and
Saline-LPS groups; Figures 2A & 2C) there were no significant
histological differences between groups. However, in the Silica-
Saline group, immediately after the end of saline inhalation
challenge we observed prominent areas of inflammation and
loosely organized fibrotic tissue (Figure 2B). Importantly, in the
Silica-LPS group immediately after the end of the LPS inhalation
challenge, we observed a greater overall degree of fibrosis and the
presence of enlarged macrophages with diffusely transparent
cytoplasm (Inset in Figure 2D) consistent with pulmonary alveolar
proteinosis [21]. While these macrophages were observed in the
Silica-Saline group, their presence was more prominent in the
Silica-LPS group.
Similarly, at 21 days after the end of inhalation challenge there
were no apparent differences between the Saline-Saline and
Saline-LPS groups (Figures 3A & 3C). As with the mice sacrificed
immediately after the end of inhalation challenge, we observed
prominent areas of inflammation and consolidated fibrotic tissue
in mice in the Silica-Saline group (Figure 3B). In the histological
sections from the Silica-LPS group mice sacrificed 21 days after
the end of inhalation challenge, we observed notable areas of
condensed fibrotic tissue with prominent collagen staining
(Figure 3D). We also observed the persistent presence of enlarged
macrophages with diffusely transparent cytoplasm (Inset in
Figure 3D) in this group of mice.
Innate Immune Stimulation in Mice Previously Exposed
to Crystalline Silica Causes a Significantly Increased
Inflammatory Response
As we and others have previously observed [17,22], exposure to
inhaled LPS alone (Saline-LPS, open square) causes an immediate
significant increase in total lung inflammatory cells when
compared to mice exposed to aerosolized saline (Saline-Saline,
closed square) (Figure 4A). Consistent with previous observations,
we show here that the majority of the inflammatory cells recruited
to the lung in response to inhaled LPS are polymorphonuclear
leukocytes (PMNs) (Figure 4C), although there are also significant
increases in total lung macrophages (Figure 4B) and lymphocytes
(Figure 4D). We also observed that, consistent with previous
reports [23], silica exposure alone (Silica-Saline, closed triangle)
significantly increased total lung inflammatory cells (Figure 4A), of
which equal numbers are PMNs (Figure 4C) and macrophages
(Figure 4B) while total lung lymphocytes are also increased
(Figure 4D). Notably, prior exposure to silica significantly increases
the immediate inflammatory response to inhaled LPS (Silica-LPS,
open triangle; Figure 4A) with the majority of the additional cells
recruited also being PMNs (Figure 4C; also compare Figure 4B
Silica-Saline and Silica-LPS showing no increase in total lung
Figure 2. Histology immediately after the end of inhalation challenge. (A) Saline-Saline; (B) Silica-Saline; (C) Saline-LPS; and (D) Silica-LPS
exposed mice immediately after the end of either saline or LPS inhalation challenge. n = 6/group. Images were taken in anatomically comparable
regions of the lung at 56 (main images) or 206 (Inset in panel D) magnification. Bar = 100 microns.
doi:10.1371/journal.pone.0040789.g002
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macrophages resulting from the combined exposure). At 21 days
after LPS exposure the immediate cellular inflammatory response
to inhaled LPS alone (Saline-LPS) resolves completely (Figure 4A
showing total cells and 4C showing total PMNs). Consistent with
previous reports there is still a significant inflammatory response to
silica exposure alone (Silica-Saline) that is comprised of macro-
phages, PMNs and lymphocytes (Figure 4A–D). Importantly, in
mice exposed to both silica and LPS (Silica-LPS) the effects of the
combined exposure cause a significant and persistent increase in
total cellular inflammation in the lung (Figure 4A). The total
number of macrophages in this group is also significantly increased
when compared to total number of macrophages recruited by
silica exposure alone (Silica-Saline).
Consistent with the cellular response we also observed that the
pro-inflammatory cytokines MCP-1, MIP-2 and KC, that are
known to recruit macrophages (MCP-1) and neutrophils (MIP-2
and KC) to sites of ongoing inflammation, are similarly increased
in whole lung lavage fluid immediately after the end of the aerosol
exposure (Figure 5). Interestingly, IL-1b which we have previously
shown to be increased by LPS inhalation alone [17] is not
significantly increased by combined exposure to silica and LPS at
this time point (Figure 5D). Notably, at 21 days after the aerosol
exposure total MCP-1 in whole lung lavage fluid remains
significantly increased in the Silica-LPS group when compared
to the Silica-Saline group at this time point (Figure 5A). There is
no difference between these groups in total MIP-2 or IL-1b at this
time point. These observations taken together show that innate
immune stimulation causes a significant and persistent increase in
whole lung inflammation in mice with pre-existing silica-induced
lung fibrosis.
To investigate the role of oxidative damage resulting from
exposure to silica and to LPS we measured the concentration of
protein carbonyls in whole lung lavage fluid [24,25]. We observed
that by themselves neither prior silica exposure (Silica-Saline) nor
LPS exposure (Saline-LPS) caused an increase in protein carbonyl
concentration in whole lung lavage fluid. However, combined
exposure to both silica and LPS (Silica-LPS) resulted in
a significant increase in protein carbonyl concentration in whole
lung lavage fluid immediately after LPS exposure (Figure 6). By 21
days after the LPS exposure there was no difference in the
concentration of protein carbonyls in whole lung lavage fluid
between any of the groups (Figure 6). These observations taken
together suggest that oxidative stress resulting from exposure to
inhaled LPS in the context of pre-existing silica-induced lung
fibrosis could be contributing to the increased collagen deposition
seen both immediately after and 21 days after LPS exposure in
Silica-LPS mice.
Blocking Oxidative Stress with N-acetylcysteine during
LPS Inhalation Attenuates Inflammation but not Fibrosis
To investigate the role of oxidative stress resulting from
exposure to silica and to LPS we exposed groups of mice to silica
Figure 3. Histology 21 days after the end of inhalation challenge. (A) Saline-Saline; (B) Silica-Saline; (C) Saline-LPS; and (D) Silica-LPS exposed
mice immediately after the end of either saline or LPS inhalation challenge. n = 6/group. Images were taken in anatomically comparable regions of
the lung at 56 (main images) or 206 (Inset in panel D) magnification. Bar = 100 microns.
doi:10.1371/journal.pone.0040789.g003
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and then to either inhaled saline or LPS as before. Groups of mice
were given either normal drinking water or drinking water
supplemented with 2 mg/ml of N-acetylcysteine (NAC), which has
previously been shown to block oxidative stress and to protect
from oxidative stress-induced airspace enlargement [18], prior to
and during LPS inhalation challenge. We observed that blocking
oxidative stress with NAC failed to protect from the enhanced
fibrosis caused by LPS inhalation challenge in silica-exposed mice
(Figure 7). However, NAC treatment prior to and during LPS
inhalation significantly reduced the total inflammatory response
(Figure 8A) by attenuating the recruitment of PMNs (Figure 8C)
while the total numbers of macrophages and lymphocytes was
unchanged. NAC treatment significantly reduced the macrophage
chemoattractant chemokine MCP-1 (Figure 9A), but not the
neutrophil-specific chemoattractant chemokines MIP-2 (Figure 9B)
or KC (Figure 9C). Interestingly, NAC treatment significantly
reduced the amount of IL-1b (Figure 9D) present in whole lung
lavage fluid.
Discussion
We have shown that innate immune stimulation with LPS in the
context of pre-existing silica-induced lung fibrosis either accel-
erates or exacerbates the existing disease. This is accompanied by
significant increases in cellular inflammation at both time points
examined and concomitant increases in pro-inflammatory cyto-
kine production. Furthermore, this is accompanied by evidence
that only combined exposure to both silica and LPS leads to an
increase in evidence of oxidative damage to proteins in whole lung
lavage fluid. However, blocking oxidative stress during the LPS
exposures failed to attenuate the observed LPS-induced increases
in hydroxyproline. These observations taken together provide
evidence that exposure of the lung to LPS, which is ubiquitous in
the environment, could lead to exacerbations or acceleration of
disease progression in patients with stable pulmonary fibrosis.
They further suggest that anti-oxidant therapy in vulnerable
patients could reduce inflammation associated with such exacer-
bations but that this treatment would likely have limited effect on
loss of normal lung architecture.
The pathogenesis of pulmonary fibrosis remains poorly un-
derstood [26]. This is due in large part to the obvious challenge
presented by the study of human end stage disease that may not
reveal the mechanistic early events that lead to later development
of fibrosis. An additional challenge is the lack of similarity of
common disease models with human lung fibrosis. Silica is
Figure 4. Whole lung lavage immediately after and 21 days after the end of inhalation challenge. (A) Total cells6105; (B) total
macrophages6105; (C) total neutrophils6105; and total lymphocytes6105. Data are presented as Mean + SEM and are representative of two such
experiments. n = 6/group. * p,0.05 LPS vs. Saline (significant difference due to inhalation challenge); # p,0.05 Silica vs. Saline (significant difference
due to silica instillation or combined Silica and LPS).
doi:10.1371/journal.pone.0040789.g004
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a biologically relevant fibrogenic environmental dust and the
resulting pathology in mice has many features in common with
human silicosis. The silica model gives us the opportunity to study
both early and late stage events in development of experimental
lung fibrosis and to use this model to understand how common
environmental exposures may accelerate or exacerbate existing
disease in human patients. Our data show that activation of innate
immunity by LPS in mice previously exposed to crystalline silica
Figure 5. Whole lung cytokines immediately after and 21 days after the end of inhalation challenge. Total (A) MCP-1; (B) MIP-2; (C) KC;
and (D) IL-1b in whole lung lavage. Data are presented as Mean + SEM and are representative of two such experiments. n = 6/group. * p,0.05 LPS vs.
Saline (significant difference due to inhalation challenge); # p,0.05 Silica vs. Saline (significant difference due to silica instillation or combined Silica
and LPS).
doi:10.1371/journal.pone.0040789.g005
Figure 6. Protein carbonyls in whole lung lavage protein.
Concentration of protein carbonyls in whole lung lavage protein
immediately after and 21 days after the end of inhalation challenge is
shown. Data are presented as Mean + SEM and are representative of
two such experiments. n = 6/group. * p,0.05 LPS vs. Saline (significant
difference due to inhalation challenge); # p,0.05 Silica vs. Saline
(significant difference due to silica instillation or combined Silica and
LPS).
doi:10.1371/journal.pone.0040789.g006
Figure 7. Hydroxyproline content in whole lung tissue in mice
treated with drinking water alone or drinking water supple-
mented with 2 mg/ml NAC during LPS exposure. Data are
presented as Mean + SEM. n= 8/group. * p,0.05 LPS vs. Saline
(significant difference due to inhalation challenge).
doi:10.1371/journal.pone.0040789.g007
LPS Exacerbates Pulmonary Fibrosis in Mice
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enhances many previously observed features of human silicosis
including inflammation, evidence of oxidative stress-induced lung
damage, collagen deposition and the presence of enlarged foamy
macrophages that are consistent with pulmonary alveolar
proteinosis [21,27]. While we observed enlarged foamy macro-
phages most prominently in the Silica-LPS groups both immedi-
ately after and 21 days after the end of the aerosol challenge it is
unclear what the role of these cells may be in the disease process.
Our observations taken together support our previously published
observations [14] and other studies [28,29] showing that LPS
inhalation by itself induces many genes that are also induced in
experimental fibrosis. Importantly, the current observations
showing that blocking oxidative stress with NAC blocks in-
flammation but not fibrosis exacerbation supports the notion that
inflammation and fibrosis are at least partially independent
processes [30,31,32,33,34].
Interestingly, the role of inflammation in development and
progression of lung fibrosis remains controversial. For example,
a recent study has demonstrated that nucleotide-binding domain
and leucine-rich repeat containing (NLR) protein family member
3 (Nalp3)-dependent pro-inflammatory mediators are critical to
development of lung fibrosis in the silica model [35] and these
multi-protein complexes contribute significantly to development of
inflammation. Interestingly, recent studies have demonstrated that
innate immune activation may play a central role in the response
to crystalline silica [36] and that macrophages in particular may
drive the complete response to silica in the lung through the
inflammasome [35,36,37].
In general, inflammasomes sense both exogenous and endog-
enous danger signals through intracellular NOD-like receptors
(NLRs) [38] that activate caspase-1 which in turn promotes
cleavage and activation of the pro-inflammatory cytokine IL-1b
[38,39]. Previous studies have shown the importance of IL-1b in
the response to crystalline silica exposure. Silica-treated macro-
phages secrete IL-1b, and IL-1b-deficient mice have an altered
inflammatory response to silica [40,41]. In addition, a poly-
morphism in the gene encoding the endogenous receptor
antagonist for the IL-1 receptor (IL-1Ra) has been associated
with increased susceptibility to silicosis in a human population
[42]. Silica exposure activates the inflammasome [43] and Nlrp3
deficient mice are protected from the effects of silica in the lung
[35] suggesting that the inflammasome is critical to a complete in
vivo response to silica. LPS has also been shown to activate the
inflammasome, and mice deficient in Caspase-1, a key component
of the inflammasome, have a primary defect in the ability to
produce and secrete IL-1b in response to LPS [44]. We therefore
hypothesized that LPS exposure would significantly enhance IL-
1b protein concentrations in whole lung lavage fluid over the
Figure 8. Whole lung lavage immediately after the end of inhalation challenge in mice treated with drinking water alone or
drinking water supplemented with 2 mg/ml NAC during LPS exposure. (A) Total cells6105; (B) total macrophages6105; (C) total
neutrophils6105; and (D) total lymphocytes6105. Data are presented as Mean + SEM. n= 8/group. * p,0.05 LPS vs. Saline (significant difference due
to inhalation challenge); ‘ p,0.05 vs. regular drinking water (significant difference due to NAC treatment alone);# p,0.05 Silica vs. Saline (significant
difference due to silica instillation or combined Silica and LPS).
doi:10.1371/journal.pone.0040789.g008
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concentrations induced by silica exposure and that this could be
causally linked to the observed increases in fibrosis. However, our
observations demonstrate clearly that LPS inhalation challenge
failed to enhance IL-1b concentrations in whole lung lavage over
silica alone. Blocking oxidative stress with NAC fails to protect
from the enhanced fibrosis seen in mice exposed to both silica and
inhaled LPS. NAC treatment significantly attenuated inflamma-
tion and the concentration of IL-1b in whole lung lavage fluid in
mice exposed to both silica and LPS while having no effect on
hydroxyproline content of the lung. These observations are
consistent with previous reports showing that inhibitors of reactive
oxygen species (ROS) inhibit IL-1b secretion [35,45]. LPS
inhalation exposure, by itself, can increase ECM gene expression
[14] and therefore, exacerbation or acceleration of fibrosis
observed in Silica-LPS mice may be a result of direct innate
immune stimulation of ECM gene expression rather than being
a by-product of enhanced inflammation.
In summary, we have demonstrated that inhalation of the
TLR4 ligand LPS, exacerbates or accelerates silica-induced
fibrotic lung disease. This was associated with increases in total
lung inflammation and in cytokines and chemokines that are
chemoattractants for macrophages and neutrophils. Additionally
we have shown that only mice exposed to both silica and LPS have
significant increases in evidence of oxidative damage in the lung
but that blocking oxidative stress with NAC fails to attenuate the
enhanced hydroxyproline deposition observed in mice exposed to
both silica and LPS. These data suggest that inhalation of
environmental LPS and possibly other TLR ligands may
contribute to exacerbation or acceleration of pre-existing disease
in patients with pulmonary fibrosis in a manner that is in-
dependent of inflammasome activation or inflammation.
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